Carla Allen Goffstein has been appointed Chief Financial Officer at New Vision Pharmaceuticals, a Morgan Stanley private equity backed pharmaceutical packaging manufacturer.
Carla joins the company as its first CFO and will lead all aspects of the business’s financial activities, driving an aggressive and transformational growth strategy. Carla brings extensive finance leadership experience in consumer packaged goods and pharmaceuticals to New Vision. She began her career at Procter & Gamble and spent her first 20+ years learning and honing best financial practices in almost every business unit. Most recently, Carla served as Chief Financial Officer for a beauty and personal care contract manufacturer in Florida. Earlier, she was the Chief Financial Officer for Twinlab Consolidated Corporation. In both companies, she played a key role in establishing new operating financial modeling, analysis, reporting, and was key to their growth strategies.
Carla holds a BS in Finance from Miami University in Ohio and serves on the board of directors as CFO and Treasurer for nonprofit Make Our Schools Safe.
About New Vision Pharmaceuticals
Headquartered in Tamarac, FL, and backed by Morgan Stanley, New Vision Pharmaceuticals is a full-service, FDA-registered contract development and manufacturing company that provides innovative solutions through blow-fill-seal (BFS), fill-seal (FS) and traditional packaging for liquid and semi-solid products in a breadth of industries, including pharmaceutical, diagnostic reagents, health, wellness, and a multitude of other applications for local and global retail markets.